Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in Pennsylvania

If you’re a psychiatrist or psychiatric mental health nurse practitioner trying to make sense of prescribing regulations, scope of practice rules, and telehealth policies across different states, you’re not alone. The rules change depending on your credentials, where your patient is located, and what medications you’re prescribing—especially controlled substances like Adderall or Xanax.

This guide cuts through the confusion. We’ll cover what you can actually do as a prescriber in telepsychiatry, how MD and NP authority differs state by state, what the current federal telehealth waivers mean for controlled substance prescribing, and how reimbursement works for medication management visits. Whether you’re looking to expand your telehealth practice or just want to stay compliant, here’s what you need to know.

The Current State of Telehealth Prescribing (2026)

Good news first: As of early 2026, you can prescribe psychiatric medications—including Schedule II controlled substances like stimulants and benzodiazepines—via telehealth to new patients without an initial in-person visit. This flexibility exists because the DEA extended its COVID-era emergency telemedicine waiver through December 31, 2025, and those extensions remain in effect.

Reality check: Federal rules are in flux. The DEA has proposed new regulations that could reimpose some in-person requirements or create special registration pathways. While nothing has finalized yet, you should monitor DEA announcements closely. The window for unrestricted teleprescribing of controlled substances may narrow by late 2026 or early 2027.

State-level nuances matter. Even with federal allowances, some states have their own telehealth prescribing restrictions:

• Florida explicitly permits telehealth prescribing of controlled substances for psychiatric treatment. A Florida-licensed psychiatrist can initiate ADHD stimulants or benzodiazepines via video visit without issue.

• Texas allows teleprescribing for mental health conditions but prohibits prescribing Schedule II opioids for chronic pain via telehealth. For psychiatric care (ADHD, anxiety, etc.), you’re fine prescribing controlled meds remotely as long as you conduct a proper telemedicine evaluation.

• New York recently finalized regulations aligning state law with federal DEA waivers, removing previous state-level barriers to controlled substance teleprescribing. NY psychiatrists can now confidently prescribe via telehealth under current federal allowances.

• California doesn’t mandate in-person exams for prescribing—a thorough telehealth exam via video satisfies California’s ‘good faith exam’ requirement. You can prescribe any psychiatric medication after a video consultation, including controlled substances, as long as you meet the standard of care.

What this means practically: Right now, you can build an entire telepsychiatry practice managing ADHD, anxiety, depression, and other conditions without seeing patients face-to-face. You must, however, ensure you’re licensed in the state where the patient is located, use secure HIPAA-compliant video platforms, and check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrist vs. PMHNP Prescribing Authority: The Real Differences

If you’re a psychiatrist (MD/DO), this section is straightforward: you have full independent prescribing authority in all 50 states. No supervision required, no collaborative agreements, no formulary restrictions beyond standard DEA registration for controlled substances. Your scope limitations come only from your own clinical competency and federal drug scheduling laws.

For psychiatric nurse practitioners (PMHNPs), it’s complicated. Your prescribing authority depends entirely on which state you’re practicing in, and the rules vary wildly.

Three Categories of NP Practice Authority

Full Practice Authority (FPA) States: About 34 states now allow experienced NPs to practice independently—no physician oversight required. In these states, a PMHNP can evaluate patients, diagnose conditions, and prescribe any psychiatric medication (including Schedule II stimulants) under their own DEA registration. Examples include Washington, Oregon, Arizona, Colorado, Minnesota, and increasingly, states like Massachusetts, Kansas, and Indiana that switched to FPA in recent years.

Reduced Practice States (Transition to Independence): Some states require initial physician collaboration but allow independence after a set period. New York requires 3,600 hours (roughly 2 years) of supervised practice, after which PMHNPs can prescribe independently. Illinois requires 4,000 hours plus 250 hours of continuing education before granting Full Practice Authority. California is transitioning—as of 2023, NPs with 3+ years experience can practice with minimal oversight in group settings (‘103 NP’ status), and by January 2026, they can apply for full independence (‘104 NP’ status).

Restricted Practice States: These states require ongoing physician supervision indefinitely. Texas is the prime example—PMHNPs must have a written Prescriptive Authority Agreement with a physician for their entire career. They cannot prescribe independently, and Texas law prohibits NPs from prescribing Schedule II controlled substances in most outpatient settings (with narrow exceptions for terminal illness or children with ADHD under very specific conditions). The physician can supervise no more than 7 NPs at once, and the agreement must include monthly meetings for the first three years.

Florida restricts psychiatric NPs despite allowing primary care NPs some autonomy. The state’s 2020 autonomous practice law excluded psychiatric nurse practitioners—PMHNPs still need physician collaboration. However, Florida does permit ‘psychiatric nurses’ (PMHNPs with 2+ years experience under a psychiatrist) to prescribe psychotropic controlled substances for mental health treatment, with no 7-day limit like other specialties face.

Pennsylvania requires all NPs to maintain collaborative agreements indefinitely—no pathway to independence exists yet, despite legislative efforts. The collaborating physician must review a portion of charts regularly and approve the NP’s prescriptive authority scope.

What This Means for Your Practice

If you’re a psychiatrist, you can practice telehealth across multiple states (with appropriate licenses) and prescribe the same medications everywhere. Your only barriers are licensing logistics and staying current on state-specific telehealth rules.

If you’re a PMHNP, you need to know:

• Where you can practice solo: In FPA states like New York (after 3,600 hours), Illinois (after 4,000 hours + training), or California (by 2026 with 104 NP status), you can eventually run your own telepsychiatry practice without a supervising physician.

• Where you need backup: In Texas, Florida, Pennsylvania, and similar restricted states, you must find a collaborating psychiatrist before you can prescribe anything. This adds cost (many physicians charge collaboration fees), administrative burden (regular meetings, chart reviews), and limits flexibility.

• Reimbursement differences: Medicare pays NPs at 85% of physician rates when billing under the NP’s own NPI. Some states mandate equal pay (‘reimbursement parity’), but in general, a psychiatrist generates higher revenue per visit than an NP for the same service—something telehealth platforms account for in their economics.

Controlled Substances and the Ryan Haight Act

The biggest regulatory headache in telepsychiatry is prescribing controlled substances—the medications many patients need most (stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder).

Federal Law (Ryan Haight Act): This 2008 law requires an in-person medical evaluation before prescribing Schedule II–V controlled substances. The intent was to prevent online pill mills. However, since March 2020, the DEA has waived this requirement under public health emergency powers, allowing providers to prescribe controlled substances via telemedicine to new patients without ever meeting them in person.

Current Status: The waiver has been extended multiple times and remains in effect through at least December 31, 2025. As of February 2026, you can still prescribe Adderall, Ritalin, Xanax, or Suboxone to a brand-new patient via a video visit, as long as you conduct a legitimate evaluation meeting the standard of care.

What’s Coming: The DEA proposed a ‘Special Registration’ system in 2023 that would require providers to register separately for telemedicine prescribing of controlled substances, potentially with limits (e.g., 30-day supply caps, referral requirements). These rules have not been finalized, and the DEA keeps extending the waivers. Most experts expect some version of telehealth flexibility to continue—mental health is a high priority politically—but the permanent framework is uncertain.

State-Specific Rules:

• Florida carved out an explicit exception for psychiatric treatment. Florida Statutes allow controlled substance prescribing via telehealth ‘for the treatment of psychiatric disorders,’ including Schedule II medications. This is unusual and very provider-friendly.

• Texas prohibits teleprescribing Schedule II opioids for chronic pain but allows it for mental health treatment (like ADHD stimulants). Texas also requires checking the state’s Prescription Drug Monitoring Program before any controlled substance prescription.

• New York recently aligned its state regulations with federal law, explicitly allowing teleprescribing of controlled substances when federal law permits it. Previously, NY had state-level restrictions that created confusion; those are now resolved.

• All states require PDMP checks. Before prescribing any Schedule II–IV medication, you must query your state’s prescription monitoring database to review the patient’s controlled substance history. This applies whether you’re seeing the patient in-person or via telehealth.

Practical Compliance Tips:

• Document thoroughly. Note that the visit was conducted via secure video, that you verified the patient’s identity and location, and that you reviewed the PDMP.
• Establish a real patient-provider relationship. A video consultation that allows adequate assessment (visual and auditory) satisfies this in nearly every state. Don’t prescribe based on a questionnaire alone.
• Have an emergency protocol. States like Texas require telehealth providers to have a plan for patient crises (e.g., if a suicidal patient disconnects). Document this protocol.
• Stay alert for federal changes. Subscribe to DEA updates and state medical board newsletters so you’re not caught off-guard if rules tighten.

Medication Management Reimbursement: What You’ll Actually Get Paid

Understanding reimbursement is critical whether you’re joining a platform like Klarity or building your own practice. Here’s how psychiatric medication management visits are billed and paid in 2026.

Common Billing Codes

Initial evaluations: Most psychiatrists use CPT 90792 (Psychiatric Diagnostic Evaluation with Medical Services) for the first visit when prescribing is involved. This is a 60-minute code. Medicare pays approximately $173 for 90792 in 2026.

Follow-up medication checks: Use standard office visit E/M codes:

• 99213 (15-20 min, moderate complexity): ~$95 from Medicare
• 99214 (25-30 min, higher complexity): ~$136 from Medicare
• 99215 (40+ min, very complex): ~$192 from Medicare (rarely used for routine med checks)

Add-on psychotherapy: If you’re combining medication management with therapy in the same session, you can bill an E/M code plus a psychotherapy add-on (90833 for 30 min therapy adds ~$80; 90838 for 60 min adds ~$135). This can significantly increase revenue per visit, but most brief med checks don’t include formal therapy.

Payer Differences

Medicare: Pays the rates above. NPs get 85% of physician rates when billing under their own NPI. Medicare has made telehealth for mental health services essentially permanent, with one caveat—some Medicare beneficiaries may need an in-person visit once every 6-12 months for certain services, but this requirement has been repeatedly waived and is not a barrier in practice as of 2026.

Private Insurance: Commercial payers often reimburse above Medicare rates, especially in high-cost markets. A psychiatrist might see $150-200 for a 99213 follow-up from Blue Cross or Aetna in California or New York. Many states now mandate telehealth payment parity—insurers must pay the same for video visits as in-person. Illinois, California, New York, and others have strong parity laws. Texas does not mandate parity, but many insurers voluntarily pay equally for tele-mental health due to demand.

Medicaid: Pays less than Medicare on average (often 60-80% of Medicare rates), but Medicaid has high volume in underserved areas. States like New York and California Medicaid reimburse telepsychiatry at par with in-person visits. Some states pay encounter rates for FQHCs or community mental health centers providing telepsychiatry.

Audio-only visits: An important recent development—Medicare and many states now reimburse audio-only mental health services (phone calls) at the same rate as video visits, to address the digital divide. This applies to brief medication management check-ins for established patients. A 20-minute phone med check can be billed as 99213 in many cases, improving access for patients without reliable internet.

Real-World Revenue Math

A psychiatrist doing telehealth medication management in a typical week might see 25-30 patients for 15-20 minute follow-ups (mostly 99213s at ~$95 each from Medicare, $120-150 from commercial insurance). That’s $2,400-4,500/week in billings for ~10-15 hours of clinical time (before overhead). Initial evaluations (90792) pay more but take longer.

An NP doing the same work bills at 85% of those rates for Medicare patients, slightly reducing revenue unless they achieve reimbursement parity through state law or ‘incident-to’ billing (which doesn’t apply in most telehealth contexts).

Cash-pay alternative: Many telepsychiatrists skip insurance entirely and charge $100-300 per visit directly. For ADHD or anxiety management, patients often pay out of pocket to avoid insurance hassles. Platforms like Klarity that handle patient acquisition can use either insurance-based or cash-pay models—providers should understand both.

State-by-State Breakdown for Priority Markets

Here’s how prescribing authority and telehealth rules shake out in six major states representing different regulatory approaches:

California

• Psychiatrists: Full independent practice and prescribing authority.
• PMHNPs: Transitioning to full independence. New grads need physician supervision (standardized procedures). As of 2023, NPs with 3+ years can practice with minimal oversight (‘103 NP’). Starting January 2026, experienced NPs can achieve full independence (‘104 NP’) with no physician required.
• Telehealth: Video exam satisfies the ‘good faith exam’ requirement for prescribing. No in-person mandate. Must check CURES (California PDMP) before Schedule II–IV prescriptions.
• Market: 1 psychiatrist per ~5,300 residents; 11+ million Californians in mental health shortage areas. High demand for telepsychiatrists.

Texas

• Psychiatrists: Full independence.
• PMHNPs: Restricted—must have a Prescriptive Authority Agreement with a physician indefinitely. Cannot prescribe Schedule II controlled substances in most outpatient settings. Physician limited to supervising 7 NPs maximum. Monthly meetings required for first 3 years.
• Telehealth: Allows teleprescribing for mental health treatment (including stimulants for ADHD). Prohibits teleprescribing Schedule II opioids for chronic pain. No payment parity mandate but high voluntary insurer compliance.
• Market: 1 psychiatrist per ~8,500 residents—one of the worst ratios in the nation. 380 mental health shortage areas needing 614+ psychiatrists. Massive demand, but NPs face strict limitations.

Florida

• Psychiatrists: Full independence.
• PMHNPs: Restricted. Primary care NPs can achieve autonomy, but psychiatric NPs were excluded from the 2020 independence law. PMHNPs must have physician collaboration. ‘Psychiatric nurses’ (PMHNPs with 2+ years under a psychiatrist) can prescribe psychotropic controlled substances without the 7-day Schedule II limit that applies to other NPs.
• Telehealth: Florida explicitly allows controlled substance prescribing via telehealth for psychiatric treatment—a major advantage. Out-of-state providers can register for telehealth but face limitations on controlled substance prescribing if not fully licensed.
• Market: 1 psychiatrist per ~9,000 residents. ~7.8 million Floridians in mental health shortage areas. High demand, especially for Spanish-speaking providers.

New York

• Psychiatrists: Full independence.
• PMHNPs: Reduced practice transitioning to full authority. New NPs need a collaborative agreement for first 3,600 hours (~2 years). After that, they can practice independently—no ongoing supervision or chart review required (just informal ‘collaborative relationship’ for referrals).
• Telehealth: 2023 regulations aligned state law with federal DEA waivers, removing barriers to teleprescribing controlled substances. Must use e-prescribing (no paper scripts) and check I-STOP registry (NY’s PDMP).
• Market: 1 psychiatrist per ~2,900 residents statewide (high concentration in NYC). Upstate regions remain underserved with 197 shortage areas needing 230+ psychiatrists. Strong telehealth parity laws.

Pennsylvania

• Psychiatrists: Full independence.
• PMHNPs: Reduced practice—must maintain collaborative agreement indefinitely. No pathway to independence yet (legislation pending). Physician must review charts regularly and approve prescriptive scope. Schedule II prescriptions limited to 30-day supply and require physician notification within 24 hours.
• Telehealth: No state-specific restrictions beyond federal law. Medicaid and major insurers cover telepsychiatry but no comprehensive parity statute yet.
• Market: 1 psychiatrist per ~4,600 residents. Rural areas face significant shortages (65 psychiatrists needed to fill gaps). High NP supply but many leave for FPA states.

Illinois

• Psychiatrists: Full independence.
• PMHNPs: Reduced practice with pathway to FPA. New NPs need collaborative agreement for 4,000 hours (2+ years) plus 250 CE hours in pharmacology. After meeting requirements, can apply for Full Practice Authority license and prescribe independently including controlled substances.
• Telehealth: Strong parity laws—private insurers must reimburse telehealth at par with in-person through at least 2027. Illinois uniquely allows licensed clinical psychologists with specialized training to prescribe limited mental health medications (under psychiatrist supervision).
• Market: 1 psychiatrist per ~5,800 residents. 291 practitioners needed to eliminate shortage areas. Growing telehealth market.

Why Traditional Patient Acquisition Is Harder Than It Looks

Before we discuss how platforms like Klarity solve this, let’s be honest about what acquiring psychiatric patients actually costs when you do it yourself.

The marketing mythology: You’ll often see advice claiming you can acquire patients for ‘$30-50 through Google Ads’ or ‘build a practice quickly with SEO.’ These numbers ignore reality.

The real economics:

SEO takes 6-12 months of consistent investment (content creation, technical optimization, backlinks) before generating meaningful patient flow. You need expertise or an agency ($2,000-5,000/month). Most solo providers don’t have the patience or budget to see this through.

Google Ads for mental health keywords ($15-40+ per click for ‘psychiatrist near me’ or ‘ADHD treatment’) with 2-5% conversion rates mean you might pay $300-800 per booked appointment—and that’s before accounting for no-shows from cold leads who Googled symptoms at 2am. Total cost per retained patient paying for ongoing care is often $500+.

Directory listings (Psychology Today, Zocdoc, etc.) charge monthly fees ($30-300/month) plus per-booking fees ($35-100+ on Zocdoc). You’re competing with hundreds of other providers on the same page. Conversion rates are unpredictable, and quality varies—many leads are price shopping or uninsured.

The hidden costs:

• Staff time to answer calls, qualify leads, handle insurance verification
• Failed campaigns and wasted ad spend during testing
• No-show rates from leads who booked but never showed (20-40% common with cold leads)
• Time you spend learning marketing instead of treating patients

Add it up: A realistic patient acquisition cost through DIY marketing is $200-500+ per patient when you factor in all costs—not just the ad click price. And that’s only if you stick with it long enough to get results.

The Klarity Model: Economics That Actually Work

Klarity Health uses a pay-per-appointment model where you only pay when a qualified patient books with you. No upfront marketing spend. No monthly subscription fees. No wasted budget on clicks that don’t convert.

Why this makes economic sense:

Pre-qualified patient flow: Klarity matches patients to your specialty and availability before they ever reach you. You’re not screening dozens of calls to find one good fit—patients who book are already qualified for your services.

Zero marketing risk: Instead of gambling $3,000-5,000/month on SEO or ads with uncertain ROI, you pay a standard listing fee per new patient appointment. Every dollar you spend results in a patient on your schedule. That’s guaranteed ROI.

Built-in telehealth infrastructure: No separate platform costs, no IT headaches, no HIPAA compliance worries. Klarity handles scheduling, reminders, documentation, and billing infrastructure.

Both insurance and cash-pay: Klarity supports credentialing with major insurance plans (you get paid at negotiated rates) and also offers cash-pay options. You control your schedule and rates—only see patients when you want to work.

For PMHNPs in restricted states: Klarity can facilitate collaborative agreements with supervising psychiatrists, removing the barrier of finding your own collaborator. This alone saves months of practice setup time and thousands in collaboration fees.

Compare the math:

• DIY marketing: $4,000/month spent, 6-10 new patients acquired (if you’re good at it), ongoing admin burden, uncertain quality. Cost per patient: $400-650.

• Klarity platform: $0 upfront, pay per appointment, 15-25+ qualified patients/month based on your availability, infrastructure included. You control how many patients you see; scale up or down instantly.

Who benefits most:

• New psychiatrists or PMHNPs building a practice from scratch
• Providers expanding into new states who don’t have local brand recognition
• Clinicians who want patient volume without running a marketing department
• Prescribers in high-demand specialties (ADHD, anxiety) who can fill their schedule quickly

Klarity isn’t the only option—some established psychiatrists do better with direct-pay concierge models or cash-only practices charging $300-500/session. But for most providers, especially those starting telehealth or scaling quickly, a platform that handles patient acquisition removes the biggest business risk entirely.

Staying Compliant: Practical Checklist

Whether you’re prescribing independently or through a platform, these compliance basics apply:

Licensing:

• Hold an active license in every state where your patients are located (not where you’re sitting)
• Consider Interstate Medical Licensure Compact if you’re an MD/DO (speeds up multistate licensing in member states)
• Track license renewal dates and CE requirements across states

DEA Registration:

• Maintain DEA registration in each state where you prescribe controlled substances
• Register in the state where you practice (your telehealth location) and any state where patients are located if required by that state’s law
• Check state-specific DEA requirements—some states require separate state controlled substance registrations

PDMP Checks:

• Query your state’s prescription monitoring database before prescribing any Schedule II–IV medication
• Document that you checked it in your clinical note
• Some states mandate checks at specific intervals (e.g., California requires checking at least every 4 months for ongoing therapy)

Documentation:

• Note that visit was conducted via telehealth (specify video or audio)
• Document patient consent for telehealth services
• Record patient’s physical location at time of visit (required for state law compliance)
• Maintain same clinical documentation standard as in-person (assessment, diagnosis, treatment plan, risks discussed)

Collaborative Agreements (NPs):

• If required in your state, maintain current written agreement with supervising physician
• File agreement with state board if required (varies by state)
• Schedule and document required meetings/chart reviews
• Update agreement if practice scope or location changes

Stay Current:

• Subscribe to state medical/nursing board updates
• Monitor DEA announcements on telehealth prescribing rules
• Track state legislative changes (scope of practice laws change frequently)
• Review payer policy updates on telehealth reimbursement

Bottom Line

Prescribing in telepsychiatry in 2026 offers unprecedented flexibility—you can manage most psychiatric conditions entirely remotely, including initiating controlled substances for ADHD and anxiety, thanks to current federal waivers and supportive state laws. The regulatory landscape varies significantly: psychiatrists enjoy universal authority while PMHNPs face state-specific restrictions ranging from full independence to mandatory physician oversight.

The economics of patient acquisition matter as much as clinical competence. Building a successful telehealth practice requires either significant marketing investment (with uncertain ROI) or partnership with platforms that handle patient flow efficiently. Platforms like Klarity remove the financial risk of DIY marketing by using a pay-per-appointment model—you only invest when patients are actually booked.

For most providers, the smart move is to focus on what you do best (treating patients) and let infrastructure platforms handle patient acquisition, scheduling, billing, and compliance logistics. The demand is there—over 122 million Americans live in mental health shortage areas. The tools are there—telehealth technology and reimbursement parity are established. The question is whether you’re positioned to capture that demand efficiently.

If you’re ready to scale your psychiatric practice with pre-qualified patient flow and zero upfront marketing costs, explore how Klarity’s telehealth platform can help you grow without the typical business risk.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship